2-96124196-G-A
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 2P and 6B. PM2BP4_StrongBP6_Moderate
The NM_001002036.4(ASTL):c.950C>T(p.Ser317Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000107 in 1,526,546 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Consequence
NM_001002036.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ASTL | NM_001002036.4 | c.950C>T | p.Ser317Leu | missense_variant | 9/9 | ENST00000342380.3 | NP_001002036.3 | |
ASTL | XM_011511205.3 | c.965C>T | p.Ser322Leu | missense_variant | 8/8 | XP_011509507.1 | ||
ASTL | XM_011511207.3 | c.911C>T | p.Ser304Leu | missense_variant | 8/8 | XP_011509509.1 | ||
ASTL | XM_011511208.3 | c.*51C>T | 3_prime_UTR_variant | 7/7 | XP_011509510.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ASTL | ENST00000342380.3 | c.950C>T | p.Ser317Leu | missense_variant | 9/9 | 1 | NM_001002036.4 | ENSP00000343674 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152166Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000736 AC: 13AN: 176680Hom.: 0 AF XY: 0.0000954 AC XY: 9AN XY: 94328
GnomAD4 exome AF: 0.000117 AC: 161AN: 1374380Hom.: 0 Cov.: 33 AF XY: 0.000132 AC XY: 89AN XY: 674458
GnomAD4 genome AF: 0.0000197 AC: 3AN: 152166Hom.: 0 Cov.: 32 AF XY: 0.0000135 AC XY: 1AN XY: 74320
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 04, 2022 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at